V

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Senior Director - US Medical Affairs, Nephrology

Biology & BiotechConfirmed live in the last 24 hours
Full-timeBoston, MA, USA

About the Job

Requirements

  • A terminal doctoral degree is required: PhD, PharmD, MD, DO, or an equivalent terminal scientific/clinical degree.
  • At least 10 years of pharmaceutical/biotechnology Medical Affairs or related scientific experience, or an equivalent combination of education and experience.
  • At least 3 years of supervisory or people-management experience leading medical or scientific teams.
  • Demonstrated ability to develop and execute medical launch strategies in the US market.
  • Strong scientific knowledge of nephrology, immunology, or related therapeutic areas, including familiarity with the US treatment landscape, clinical trial design, and evidence generation.
  • Ability to build trusted relationships internally across functions and externally with thought leaders and academic experts.
  • Ability to drive execution and deliver results in a highly matrixed, cross-functional environment.
  • Ability to write and speak effectively and influence senior leadership, cross-functional partners, and external stakeholders.
  • Ability to critically analyze and interpret complex scientific data and translate it into medical strategy.
  • Track record of planning, initiating, and completing high-impact projects within established timelines.
  • Ability to manage shifting priorities in a rapidly changing, pre-launch or launch environment.

Responsibilities

  • Lead development, execution, and ongoing refinement of the US Medical Affairs strategic and operational plan for assigned nephrology assets from pre-launch through lifecycle management.
  • Serve as the primary internal medical-scientific authority for the assigned asset, interpret clinical trial data, real-world evidence, and published literature, and translate insights into actionable medical strategy.
  • Cultivate and maintain scientific relationships with US nephrology thought leaders, academic investigators, and key external experts to inform medical strategy and support evidence generation.
  • Partner with Commercial, Market Access, HEOR, Regulatory, Clinical Development, and Corporate Communications to ensure aligned launch readiness and integrated execution in a matrix environment.
  • Drive the design and execution of medical evidence generation initiatives, including investigator-sponsored research, advisory boards, and medical education programs, aligned with asset strategy and US medical needs.
  • Deliver and oversee fair, balanced, and compliant scientific presentations and communications to healthcare professionals, payers, and other stakeholders.
  • Provide strategic medical input into promotional and non-promotional material review (CRC/MLR), ensuring claims are scientifically substantiated and compliant with Vertex policies and US regulations.
  • Establish and track medical key performance indicators demonstrating impact on business outcomes and patient care; use scenario planning and market foresight to adapt strategies to a dynamic launch environment.
  • Ensure activities comply with Vertex policies, US laws and regulations, GCP, ICH guidelines, and applicable codes of practice.
  • Build and lead a growing team of Medical Directors and Associate Medical Directors.

Desired Qualifications

  • Prior launch experience in nephrology, immunology, or rare disease is strongly preferred.
  • Experience managing and developing teams of Medical Directors and/or Associate Medical Directors is a plus.
  • Nephrology-specific scientific expertise is preferred but not required; deep therapeutic-area knowledge in a related immune-mediated or rare disease is acceptable.

About the Company

Vertex Pharmaceuticals

Develops therapies for serious genetic diseases

Vertex Pharmaceuticals develops medicines for serious diseases, with a focus on cystic fibrosis. It conducts extensive research and partners with other biotech firms to discover and develop new therapies, including ex vivo engineered cell treatments. Its products, such as ivacaftor, treat cystic fibrosis and other therapies undergo clinical testing to expand the pipeline. Revenue comes from selling approved drugs and from licensing and collaboration agreements. The company distinguishes itself through deep R&D investment, strategic partnerships, and a global reach aimed at addressing unmet medical needs. The overall goal is to bring effective new drugs to patients worldwide and improve outcomes and quality of life.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1989

Recently Posted Jobs

Explore more opportunities at Vertex Pharmaceuticals

See more jobs